Jiangsu Nhwa Pharmaceutical Co., Ltd. Jiangsu Nhwa Pharmaceutical Co., Ltd.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

002262

Rangering i aksjer #4607
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Aksjekurs
$3.28
Markedsverdi
$3.32B
Endring (1 dag)
4.19%
Endring (1 år)
-10.41%
Land
CN
Handel Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)

Kategori

Healthcare
Historikk for aksjesplitt for Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Aksjen Jiangsu Nhwa Pharmaceutical Co., Ltd. (symbol: 002262) har gjennomgått totalt 7 aksjesplitt.
Den nyeste splittelsen skjedde May 12, 2017.
Én 002262-aksje kjøpt før Jun 10, 2009 tilsvarer i dag 7.3008 002262-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
2017-05-12 8:5 x1.6 x7.3008
2016-06-08 13:10 x1.3 x4.563
2015-04-08 6:5 x1.2 x3.51
2014-05-28 6:5 x1.2 x2.925
2013-06-05 5:4 x1.25 x2.4375
2010-06-01 13:10 x1.3 x1.95
2009-06-10 3:2 x1.5 x1.5
Aksjesplitt for lignende selskaper eller konkurrenter